Demographics (2)
- Dx_AGE - Subject age at diagnosis (phv00543852.v1.p1)
- SEX - Biological sex (phv00543840.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00543846.v1.p1)
- RACE - Self-reported race (phv00543845.v1.p1)
Other (17)
- AFFECTION_STATUS - Status of the subject for Acute Myeloid Leukemia (AML); all subjects are AML patients. (phv00543844.v1.p1)
- AHD - Whether subject had antecedent hematological disorder (phv00543847.v1.p1)
- ANALYTE_TYPE - Analyte Type (DNA)-use of MissionBio Myeloid 45-gene panel for targeted sequencing (phv00543856.v1.p1)
- BODY_SITE - Site on the body from which sample was collected (phv00543855.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00543839.v1.p1)
- CYTOGENETICS - Cytogenetics of sample associated with subject (phv00543853.v1.p1)
- ELN17 - European Leukemianet 2017 Classification (phv00543848.v1.p1)
- ELN22 - European Leukemianet 2022 Classification (phv00543849.v1.p1)
- HAD_CR - Whether subject experienced complete remission (CR) or not. (phv00543850.v1.p1)
- IS_RELAPSE - Whether subject's case is a relapse or a new diagnosis (phv00543851.v1.p1)
- IS_TUMOR - Whether sample is from a tumor (phv00543858.v1.p1)
- SAMPLE_ID - Sample ID (phv00543854.v1.p1)
- SAMPLE_ID - Sample ID (phv00543842.v1.p1)
- SECONDARY_ANALYTE - Secondary Analyte Type (Protein) TotalSeq-D Human Heme Oncology Cocktail, V1.0 (BioLegened) panel of 42 antibodies to surface markers (phv00543857.v1.p1)
- SUBJECT_ID - Subject ID (phv00543843.v1.p1)
- SUBJECT_ID - Subject ID (phv00543838.v1.p1)
- SUBJECT_ID - Subject ID (phv00543841.v1.p1)